Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Receivables - Other (2013 - 2025)

Scynexis' (SCYX) quarterly Receivables - Other came in at $9.5 million in Q1 2025, down 51.15% on a YoY basis from $19.5 million in Q1 2024, and little changed quarter-over-quarter from $9.5 million in Q4 2024.

Analysis

Scynexis (SCYX) Receivables - Other (2013 - 2025) Analysis & Trends

Scynexis (SCYX) has reported Receivables - Other for 11 consecutive years, with $9.5 million the latest figure, recorded in Q1 2025.

  • For the quarter ending Q1 2025, Receivables - Other fell 51.15% year-over-year to $9.5 million; the trailing twelve-month figure through Mar 2025 stood at $9.5 million (down 51.15% YoY), and the FY2024 full-year result was $9.5 million, down 50.89% from the prior year.
  • Receivables - Other steadied at $9.5 million in Q1 2025 per SCYX's latest filing, from $9.5 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $19.5 million in Q2 2024 and bottomed at $1.0 million in Q1 2021.
  • Historically, Receivables - Other has averaged $14.0 million across 4 years, with a median of $19.2 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Receivables - Other advanced 1.35% in 2024, then slumped 51.15% in 2025.
  • Over 4 years, Receivables - Other stood at $1.0 million in 2021, then jumped by 1836.3% to $19.4 million in 2023, then tumbled by 50.89% to $9.5 million in 2024, then changed by 0.0% to $9.5 million in 2025.
  • According to Business Quant data, Receivables - Other over the past three periods registered $9.5 million, $9.5 million, and $9.5 million for Q1 2025, Q4 2024, and Q3 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Scynexis 58.41 Mn -56.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 9.51 Mn
Dec 31, 2024 9.51 Mn
Sep 30, 2024 9.51 Mn
Jun 30, 2024 19.51 Mn
Mar 31, 2024 19.47 Mn
Dec 31, 2023 19.36 Mn
Sep 30, 2023 19.31 Mn
Jun 30, 2023 19.25 Mn
Mar 31, 2021 1.00 Mn
Dec 31, 2020 2.88 Mn
Sep 30, 2018 175,000.00
Jun 30, 2018 175,000.00
Mar 31, 2018 251,000.00
Dec 31, 2017 251,000.00
Sep 30, 2017 251,000.00
Jun 30, 2017 300,000.00
Mar 31, 2017 300,000.00
Dec 31, 2016 233,000.00
Sep 30, 2016 1.02 Mn
Jun 30, 2016 816,000.00